ACOG/LinkedIn
Oct 15, 2025, 09:08
ACOG Publishes Clinical Update on Postpartum Zuranolone Therapy
American College of Obstetricians and Gynecologists (ACOG) shared a post on LinkedIn:
“ACOG’s latest Clinical Practice Update makes finding the guidance you need on treating depression with zuranolone during the postpartum period easier to find, understand, and put into practice, with clear recommendations, implementation considerations, and more. The guidance also answers questions about clinical scenarios that may arise when considering zuranolone and includes newly available data about concentrations of zuranolone in human milk. Read the guidance.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 3, 2026, 00:23Final Call for Review of Updated ESHRE IVF Laboratory Recommendations – ESHRE
-
Mar 3, 2026, 00:15Abstract Submissions Are Now Open for ASM 2026! – BSGI
-
Mar 2, 2026, 14:06Ever Wondered How Ovulation Works? Let’s Break It Down! – Fertility Plus
-
Mar 2, 2026, 13:48Join RBMO Webinar on Global Declining Fertility Rates – RBMO
-
Mar 2, 2026, 13:39Governance of Polygenic Embryo Screening – Fertility and Sterility
-
Mar 2, 2026, 13:26AJOG MFM February 2026 Podcast Episode Is Out!
-
Mar 2, 2026, 13:21Yousef Zakharia Leads Clinical Research Aimed at Genitourinary Cancers – Mayo Clinic
-
Mar 1, 2026, 16:41Exploring Frozen and Fresh Embryo Transfer Risks – Fertility and Sterility
-
Mar 1, 2026, 16:40Foraviset Welcomes Prof. Tasuku Harada to Advisory Board – Foraviset